Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, grantg2, StockWizard, Big_Money_Upward, Peacefulwendy
Search This Board:
Last Post: 12/19/2014 11:17:27 PM - Followers: 292 - Board type: Free - Posts Today: 0

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 12/15/2014 08:05:00 AM
ONVO News: Statement of Changes in Beneficial Ownership (4) 12/09/2014 04:49:04 PM
ONVO News: Initial Statement of Beneficial Ownership (3) 12/09/2014 04:47:37 PM
ONVO News: Current Report Filing (8-k) 12/08/2014 04:49:00 PM
ONVO News: Organovo Appoints Dr. Kirk Malloy to Board of Directors 12/08/2014 08:05:00 AM
#7461  Sticky Note CNBC Fast Money/Smart Money Segment: Peacefulwendy 12/12/14 11:35:52 AM
#7214  Sticky Note Article today on CNN money shorty355 11/04/14 10:44:51 AM
#6278  Sticky Note ONVO news: "Organovo Reports Positive Results from a rayank 06/26/14 10:25:47 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#7547   Remember, it's the holidays. Thin trading, etc. rumper 12/19/14 11:17:27 PM
#7546   Looking to break through $7.63 resistance level next week. u3ratsinabag 12/19/14 10:22:15 PM
#7545   you sure it was 447,000? I'm seeing u3ratsinabag 12/19/14 09:57:37 PM
#7544   447000 single trade after ours. Volume 500k. Loco Motion 12/19/14 06:47:44 PM
#7543   Some confusion on the official 'close' vs 'last trade'. Alvie 12/19/14 05:07:03 PM
#7542   What? It closed at $7.24 UP $.50 or RandolRocketman 12/19/14 04:51:53 PM
#7541   What kind of costs are companies looking at RallyTheMarket 12/19/14 04:06:56 PM
#7540   That was BS at the close. 7.13 and Loco Motion 12/19/14 04:03:01 PM
#7539   Honorable mention in Fortune: Big_Money_Upward 12/19/14 03:39:24 PM
#7538   With thoughts like that you hand the win RallyTheMarket 12/19/14 02:01:58 PM
#7537   Gltu johncon 12/19/14 01:09:27 PM
#7536   Not very likely that Shorts & MMs can grantg2 12/19/14 12:58:32 PM
#7535   This investor accumulated in the dollar range when johncon 12/19/14 12:34:17 PM
#7534   Not exciting ONLY IF ONVO was bot at grantg2 12/18/14 04:44:45 PM
#7533   I also would certainly hope that in three RallyTheMarket 12/18/14 02:44:03 PM
#7532   It's not discounting progress in the lab. When RallyTheMarket 12/18/14 02:42:58 PM
#7530   Yes... a fact... and a MEANINGLESS statistic (IMO) grantg2 12/18/14 02:10:00 PM
#7529   Nor does it mean that they HAVE to. RallyTheMarket 12/18/14 01:50:20 PM
#7528   All it means is that it would TAKE RallyTheMarket 12/18/14 01:45:57 PM
#7527   Days to cover. A measurement of a company's johncon 12/18/14 01:08:45 PM
#7526   $2 buy AGAIN, I would love. Pre market dshade 12/18/14 11:12:37 AM
#7525   If you're thinking that means in 12 days RallyTheMarket 12/18/14 10:42:32 AM
#7524   Anything is a climb after you fall from RallyTheMarket 12/18/14 10:40:54 AM
#7523   Calling for the end of the FDA because RallyTheMarket 12/18/14 10:38:51 AM
#7522   3D printing video going viral, helping entire sector: https://www. Big_Money_Upward 12/18/14 09:05:45 AM
#7521   very good morning for ONVO chaostrader 12/18/14 08:58:34 AM
#7520   Trading above 7 in the pre-market - buys Alvie 12/18/14 08:49:38 AM
#7519   Still December and climbing, as predicted. dshade 12/18/14 08:24:33 AM
#7517   ONVO could make the FDA obsolete. rumper 12/17/14 06:54:39 PM
#7515   Why do they have to cover in 12 days? grantg2 12/17/14 04:12:51 PM
#7514   12 days for shorts to cover. Lot of johncon 12/17/14 04:10:51 PM
#7513   Cramer bullish on ONVO: (not that it means rayank 12/17/14 08:21:33 AM
#7512   I don't know about a show of hands Alvie 12/16/14 06:14:29 PM
#7511   Shorts must've loved that CNBC exposure. Great new RallyTheMarket 12/16/14 04:47:24 PM
#7510   anyone catch that 1/2 a million $ buy u3ratsinabag 12/16/14 12:19:04 PM
#7509   The short desperation tries to stop the science dshade 12/16/14 09:45:31 AM
#7508   In <3 yrs from $2 to $6 and dshade 12/16/14 09:42:43 AM
#7507   What is your opinion on how a takeover 72vett 12/16/14 09:34:40 AM
#7506   Correct rumper and ahead of schedule with more dshade 12/16/14 07:55:27 AM
#7505   ONVOs management is doing a splendid job. rumper 12/15/14 06:32:37 PM
#7504   I don't think this management has what it RallyTheMarket 12/15/14 05:58:33 PM
#7503   You'll have to add ignoring the month-to-month as RallyTheMarket 12/15/14 05:56:58 PM
#7501   Actually I've purchased several lots from 5.50-6. And RallyTheMarket 12/15/14 05:41:23 PM
#7499   You didn't buy any at 5.50? Really!? Incredible. dshade 12/15/14 04:42:13 PM
#7493   Up, as I keep saying. Buy dips and dshade 12/15/14 03:51:27 PM
#7492   Not sure, but intraday chart shows a head StockWizard 12/15/14 01:26:04 PM
#7491   Should it now? Where do you see this RallyTheMarket 12/15/14 01:24:44 PM
#7490   Wash rinse repeat. Then they short again at RallyTheMarket 12/15/14 01:24:09 PM
#7489   Yup once the gap closes it should move StockWizard 12/15/14 10:40:54 AM
#7488   Yeah $7 has some resistance we need to rayank 12/15/14 10:31:56 AM